Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations
To access this article, please choose from the options below
PII: S0169-5002(10)00068-1
doi:10.1016/j.lungcan.2010.02.003
© 2010 Elsevier Ireland Ltd. All rights reserved.
